Learn more about whether BioMarin Pharmaceutical Inc. or CRISPR Therapeutics AG is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Once a drug target is identified, it often takes decades until a chemical compound is developed that can hit the bullseye and ...
The FDA previously placed two clinical studies on hold, including the Phase III trial in which the liver toxicity occurred.
Jarome and his team found that aging disrupts K63 polyubiquitination in two distinct areas of the brain. In the hippocampus, ...
Explore CRISPR technology explained, gene editing science, DNA modification, and genetic engineering ethics—discover how ...
Virginia Tech researchers have shown that memory loss in aging may be reversible. Using CRISPR tools, they corrected molecular disruptions in the hippocampus and amygdala, restoring memory in older ...
It is a smart strategy to diversify your portfolio by investing in high-quality companies built on proven technologies.
An international joint research team, including scientists from Switzerland, has revealed the origin of human fingers through ...
This important study examines the potential role of ARHGAP36 transcriptional regulation by FOXC1 in controlling sonic hedgehog signaling in human neuroblastoma. While there are many solid findings ...
By tweaking the epigenetic state of a single gene, Arc, inside memory-storing neurons, researchers have altered memory ...
Emerging genetics research could help brands create mainstream wheat products that are safer for gluten-sensitive consumers – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback